nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—esophageal cancer	0.64	1	CbGaD
Loratadine—CYP2C9—Capecitabine—esophageal cancer	0.0601	0.433	CbGbCtD
Loratadine—CYP2C9—Cisplatin—esophageal cancer	0.0303	0.218	CbGbCtD
Loratadine—ABCB1—Cisplatin—esophageal cancer	0.0294	0.212	CbGbCtD
Loratadine—ABCB1—Methotrexate—esophageal cancer	0.0191	0.137	CbGbCtD
Loratadine—Ketotifen—PDE4D—esophageal cancer	0.00772	0.803	CrCbGaD
Loratadine—Urine color abnormal—Capecitabine—esophageal cancer	0.00367	0.0781	CcSEcCtD
Loratadine—Chromaturia—Capecitabine—esophageal cancer	0.00242	0.0515	CcSEcCtD
Loratadine—Desloratadine—ABCB1—esophageal cancer	0.0019	0.197	CrCbGaD
Loratadine—Pain—Carboplatin—esophageal cancer	0.00122	0.026	CcSEcCtD
Loratadine—Blister—Capecitabine—esophageal cancer	0.0012	0.0255	CcSEcCtD
Loratadine—Body temperature increased—Carboplatin—esophageal cancer	0.00113	0.024	CcSEcCtD
Loratadine—Increased appetite—Capecitabine—esophageal cancer	0.000668	0.0142	CcSEcCtD
Loratadine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000656	0.014	CcSEcCtD
Loratadine—Lethargy—Capecitabine—esophageal cancer	0.00064	0.0136	CcSEcCtD
Loratadine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00062	0.0132	CcSEcCtD
Loratadine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000573	0.0122	CcSEcCtD
Loratadine—Gastritis—Capecitabine—esophageal cancer	0.000555	0.0118	CcSEcCtD
Loratadine—Tinnitus—Cisplatin—esophageal cancer	0.000549	0.0117	CcSEcCtD
Loratadine—Immune system disorder—Cisplatin—esophageal cancer	0.000532	0.0113	CcSEcCtD
Loratadine—Arrhythmia—Cisplatin—esophageal cancer	0.000526	0.0112	CcSEcCtD
Loratadine—Alopecia—Cisplatin—esophageal cancer	0.00052	0.0111	CcSEcCtD
Loratadine—Depression—Capecitabine—esophageal cancer	0.000482	0.0103	CcSEcCtD
Loratadine—Lethargy—Methotrexate—esophageal cancer	0.000477	0.0101	CcSEcCtD
Loratadine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000476	0.0101	CcSEcCtD
Loratadine—Malaise—Cisplatin—esophageal cancer	0.000462	0.00984	CcSEcCtD
Loratadine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000457	0.00973	CcSEcCtD
Loratadine—Epistaxis—Capecitabine—esophageal cancer	0.000456	0.0097	CcSEcCtD
Loratadine—Myalgia—Cisplatin—esophageal cancer	0.000436	0.00929	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000433	0.00922	CcSEcCtD
Loratadine—Discomfort—Cisplatin—esophageal cancer	0.000431	0.00917	CcSEcCtD
Loratadine—Pharyngitis—Capecitabine—esophageal cancer	0.000431	0.00917	CcSEcCtD
Loratadine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000418	0.0089	CcSEcCtD
Loratadine—Nervous system disorder—Cisplatin—esophageal cancer	0.00041	0.00873	CcSEcCtD
Loratadine—Tachycardia—Cisplatin—esophageal cancer	0.000408	0.00869	CcSEcCtD
Loratadine—Skin disorder—Cisplatin—esophageal cancer	0.000406	0.00865	CcSEcCtD
Loratadine—Tinnitus—Capecitabine—esophageal cancer	0.000405	0.00861	CcSEcCtD
Loratadine—Immune system disorder—Capecitabine—esophageal cancer	0.000392	0.00834	CcSEcCtD
Loratadine—Hypotension—Cisplatin—esophageal cancer	0.000391	0.00832	CcSEcCtD
Loratadine—Arrhythmia—Capecitabine—esophageal cancer	0.000388	0.00825	CcSEcCtD
Loratadine—Alopecia—Capecitabine—esophageal cancer	0.000383	0.00816	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000381	0.00811	CcSEcCtD
Loratadine—Paraesthesia—Cisplatin—esophageal cancer	0.000376	0.00799	CcSEcCtD
Loratadine—Dysgeusia—Capecitabine—esophageal cancer	0.00037	0.00787	CcSEcCtD
Loratadine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000361	0.00769	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—esophageal cancer	0.00036	0.00766	CcSEcCtD
Loratadine—Depression—Methotrexate—esophageal cancer	0.000359	0.00764	CcSEcCtD
Loratadine—Pain—Cisplatin—esophageal cancer	0.000358	0.00761	CcSEcCtD
Loratadine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000351	0.00746	CcSEcCtD
Loratadine—Feeling abnormal—Cisplatin—esophageal cancer	0.000345	0.00734	CcSEcCtD
Loratadine—Malaise—Capecitabine—esophageal cancer	0.000341	0.00725	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00034	0.00724	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—esophageal cancer	0.000339	0.00722	CcSEcCtD
Loratadine—Syncope—Capecitabine—esophageal cancer	0.000339	0.00721	CcSEcCtD
Loratadine—Palpitations—Capecitabine—esophageal cancer	0.000334	0.00711	CcSEcCtD
Loratadine—Loss of consciousness—Capecitabine—esophageal cancer	0.000332	0.00707	CcSEcCtD
Loratadine—Body temperature increased—Cisplatin—esophageal cancer	0.000331	0.00704	CcSEcCtD
Loratadine—Cough—Capecitabine—esophageal cancer	0.00033	0.00702	CcSEcCtD
Loratadine—Hypertension—Capecitabine—esophageal cancer	0.000326	0.00694	CcSEcCtD
Loratadine—Chest pain—Capecitabine—esophageal cancer	0.000322	0.00685	CcSEcCtD
Loratadine—Myalgia—Capecitabine—esophageal cancer	0.000322	0.00685	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—esophageal cancer	0.000321	0.00682	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000319	0.0068	CcSEcCtD
Loratadine—Discomfort—Capecitabine—esophageal cancer	0.000318	0.00676	CcSEcCtD
Loratadine—Dry mouth—Capecitabine—esophageal cancer	0.000315	0.00669	CcSEcCtD
Loratadine—Shock—Capecitabine—esophageal cancer	0.000303	0.00646	CcSEcCtD
Loratadine—Nervous system disorder—Capecitabine—esophageal cancer	0.000302	0.00644	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—esophageal cancer	0.000301	0.00641	CcSEcCtD
Loratadine—Tachycardia—Capecitabine—esophageal cancer	0.000301	0.0064	CcSEcCtD
Loratadine—Asthenia—Cisplatin—esophageal cancer	0.0003	0.00639	CcSEcCtD
Loratadine—Skin disorder—Capecitabine—esophageal cancer	0.000299	0.00637	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—esophageal cancer	0.000292	0.00621	CcSEcCtD
Loratadine—Hypotension—Capecitabine—esophageal cancer	0.000288	0.00613	CcSEcCtD
Loratadine—Diarrhoea—Cisplatin—esophageal cancer	0.000286	0.00609	CcSEcCtD
Loratadine—Alopecia—Methotrexate—esophageal cancer	0.000285	0.00608	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000281	0.00598	CcSEcCtD
Loratadine—Insomnia—Capecitabine—esophageal cancer	0.000279	0.00594	CcSEcCtD
Loratadine—Paraesthesia—Capecitabine—esophageal cancer	0.000277	0.00589	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—esophageal cancer	0.000275	0.00586	CcSEcCtD
Loratadine—Dyspepsia—Capecitabine—esophageal cancer	0.000271	0.00578	CcSEcCtD
Loratadine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000266	0.00567	CcSEcCtD
Loratadine—Vomiting—Cisplatin—esophageal cancer	0.000266	0.00566	CcSEcCtD
Loratadine—Fatigue—Capecitabine—esophageal cancer	0.000266	0.00566	CcSEcCtD
Loratadine—Rash—Cisplatin—esophageal cancer	0.000264	0.00561	CcSEcCtD
Loratadine—Pain—Capecitabine—esophageal cancer	0.000264	0.00561	CcSEcCtD
Loratadine—Constipation—Capecitabine—esophageal cancer	0.000264	0.00561	CcSEcCtD
Loratadine—Dermatitis—Cisplatin—esophageal cancer	0.000263	0.00561	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000261	0.00555	CcSEcCtD
Loratadine—Feeling abnormal—Capecitabine—esophageal cancer	0.000254	0.00541	CcSEcCtD
Loratadine—Malaise—Methotrexate—esophageal cancer	0.000254	0.0054	CcSEcCtD
Loratadine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000252	0.00537	CcSEcCtD
Loratadine—Nausea—Cisplatin—esophageal cancer	0.000248	0.00529	CcSEcCtD
Loratadine—Cough—Methotrexate—esophageal cancer	0.000245	0.00522	CcSEcCtD
Loratadine—Body temperature increased—Capecitabine—esophageal cancer	0.000244	0.00519	CcSEcCtD
Loratadine—Abdominal pain—Capecitabine—esophageal cancer	0.000244	0.00519	CcSEcCtD
Loratadine—Myalgia—Methotrexate—esophageal cancer	0.000239	0.0051	CcSEcCtD
Loratadine—Chest pain—Methotrexate—esophageal cancer	0.000239	0.0051	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000238	0.00506	CcSEcCtD
Loratadine—Discomfort—Methotrexate—esophageal cancer	0.000237	0.00503	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00023	0.00488	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—esophageal cancer	0.000225	0.00479	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—esophageal cancer	0.000223	0.00474	CcSEcCtD
Loratadine—Asthenia—Capecitabine—esophageal cancer	0.000221	0.00471	CcSEcCtD
Loratadine—Hypotension—Methotrexate—esophageal cancer	0.000214	0.00456	CcSEcCtD
Loratadine—Diarrhoea—Capecitabine—esophageal cancer	0.000211	0.00449	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000209	0.00445	CcSEcCtD
Loratadine—Insomnia—Methotrexate—esophageal cancer	0.000208	0.00442	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—esophageal cancer	0.000206	0.00439	CcSEcCtD
Loratadine—Somnolence—Methotrexate—esophageal cancer	0.000204	0.00434	CcSEcCtD
Loratadine—Dizziness—Capecitabine—esophageal cancer	0.000204	0.00434	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—esophageal cancer	0.000202	0.0043	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000198	0.00422	CcSEcCtD
Loratadine—Fatigue—Methotrexate—esophageal cancer	0.000198	0.00421	CcSEcCtD
Loratadine—Pain—Methotrexate—esophageal cancer	0.000196	0.00418	CcSEcCtD
Loratadine—Vomiting—Capecitabine—esophageal cancer	0.000196	0.00417	CcSEcCtD
Loratadine—Rash—Capecitabine—esophageal cancer	0.000194	0.00414	CcSEcCtD
Loratadine—Dermatitis—Capecitabine—esophageal cancer	0.000194	0.00413	CcSEcCtD
Loratadine—Headache—Capecitabine—esophageal cancer	0.000193	0.00411	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—esophageal cancer	0.000189	0.00403	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000188	0.00399	CcSEcCtD
Loratadine—Nausea—Capecitabine—esophageal cancer	0.000183	0.0039	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—esophageal cancer	0.000181	0.00386	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—esophageal cancer	0.000181	0.00386	CcSEcCtD
Loratadine—Asthenia—Methotrexate—esophageal cancer	0.000165	0.0035	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—esophageal cancer	0.000157	0.00334	CcSEcCtD
Loratadine—Dizziness—Methotrexate—esophageal cancer	0.000152	0.00323	CcSEcCtD
Loratadine—Vomiting—Methotrexate—esophageal cancer	0.000146	0.00311	CcSEcCtD
Loratadine—Rash—Methotrexate—esophageal cancer	0.000145	0.00308	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—esophageal cancer	0.000145	0.00308	CcSEcCtD
Loratadine—Headache—Methotrexate—esophageal cancer	0.000144	0.00306	CcSEcCtD
Loratadine—Nausea—Methotrexate—esophageal cancer	0.000136	0.0029	CcSEcCtD
Loratadine—ABCB1—Metabolism—CA1—esophageal cancer	6.37e-05	0.000388	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.37e-05	0.000388	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	6.29e-05	0.000383	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.29e-05	0.000383	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.26e-05	0.000381	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—GHRL—esophageal cancer	6.23e-05	0.000379	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ADH7—esophageal cancer	6.22e-05	0.000379	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PLCE1—esophageal cancer	6.22e-05	0.000379	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PFN1—esophageal cancer	6.2e-05	0.000378	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.15e-05	0.000374	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.15e-05	0.000374	CbGpPWpGaD
Loratadine—HRH1—G alpha (q) signalling events—PIK3CA—esophageal cancer	6.1e-05	0.000372	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	6e-05	0.000366	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA1—esophageal cancer	6e-05	0.000366	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CA2—esophageal cancer	5.97e-05	0.000364	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA1—esophageal cancer	5.95e-05	0.000363	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	5.95e-05	0.000363	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.84e-05	0.000355	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CA2—esophageal cancer	5.83e-05	0.000355	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ELMO1—esophageal cancer	5.57e-05	0.000339	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.55e-05	0.000338	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PLCE1—esophageal cancer	5.55e-05	0.000338	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ADH7—esophageal cancer	5.55e-05	0.000338	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CA2—esophageal cancer	5.49e-05	0.000334	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.49e-05	0.000334	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	5.46e-05	0.000332	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ADH1B—esophageal cancer	5.45e-05	0.000332	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKAP13—esophageal cancer	5.45e-05	0.000332	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CA2—esophageal cancer	5.44e-05	0.000332	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PLCE1—esophageal cancer	5.42e-05	0.00033	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ADH7—esophageal cancer	5.42e-05	0.00033	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.37e-05	0.000327	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.32e-05	0.000324	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TYMP—esophageal cancer	5.21e-05	0.000317	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.11e-05	0.000311	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ADH7—esophageal cancer	5.11e-05	0.000311	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PLCE1—esophageal cancer	5.11e-05	0.000311	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	5.07e-05	0.000309	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PLCE1—esophageal cancer	5.06e-05	0.000308	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ADH7—esophageal cancer	5.06e-05	0.000308	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.03e-05	0.000306	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5e-05	0.000305	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDE4D—esophageal cancer	4.98e-05	0.000303	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALOX15—esophageal cancer	4.94e-05	0.000301	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ADH1B—esophageal cancer	4.87e-05	0.000296	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ADH1B—esophageal cancer	4.75e-05	0.000289	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GNG7—esophageal cancer	4.74e-05	0.000289	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TPI1—esophageal cancer	4.71e-05	0.000287	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTO1—esophageal cancer	4.71e-05	0.000287	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TYMP—esophageal cancer	4.65e-05	0.000283	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.65e-05	0.000283	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.62e-05	0.000281	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.62e-05	0.000281	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TYMP—esophageal cancer	4.54e-05	0.000277	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	4.52e-05	0.000276	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALDOB—esophageal cancer	4.52e-05	0.000275	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.48e-05	0.000273	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.46e-05	0.000271	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—XIAP—esophageal cancer	4.44e-05	0.00027	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ADH1B—esophageal cancer	4.44e-05	0.00027	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.42e-05	0.000269	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALOX15—esophageal cancer	4.41e-05	0.000269	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.36e-05	0.000265	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GAPDH—esophageal cancer	4.35e-05	0.000265	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CRABP1—esophageal cancer	4.31e-05	0.000263	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALOX15—esophageal cancer	4.3e-05	0.000262	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TYMP—esophageal cancer	4.28e-05	0.000261	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TYMP—esophageal cancer	4.24e-05	0.000258	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTO1—esophageal cancer	4.21e-05	0.000256	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TPI1—esophageal cancer	4.21e-05	0.000256	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNA1—esophageal cancer	4.2e-05	0.000256	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL2—esophageal cancer	4.17e-05	0.000254	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	4.16e-05	0.000253	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	4.13e-05	0.000251	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TPI1—esophageal cancer	4.11e-05	0.00025	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTO1—esophageal cancer	4.11e-05	0.00025	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GNG7—esophageal cancer	4.1e-05	0.00025	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALOX15—esophageal cancer	4.06e-05	0.000247	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALDOB—esophageal cancer	4.03e-05	0.000246	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALOX15—esophageal cancer	4.02e-05	0.000245	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALDOB—esophageal cancer	3.94e-05	0.00024	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.93e-05	0.000239	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA1—esophageal cancer	3.93e-05	0.000239	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PSME2—esophageal cancer	3.9e-05	0.000237	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PSME1—esophageal cancer	3.9e-05	0.000237	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.88e-05	0.000236	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ANXA1—esophageal cancer	3.88e-05	0.000236	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.87e-05	0.000236	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TPI1—esophageal cancer	3.87e-05	0.000236	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.85e-05	0.000234	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.84e-05	0.000234	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TPI1—esophageal cancer	3.84e-05	0.000234	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.84e-05	0.000234	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GAPDH—esophageal cancer	3.79e-05	0.000231	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.78e-05	0.00023	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SST—esophageal cancer	3.77e-05	0.00023	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CRABP1—esophageal cancer	3.76e-05	0.000229	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.71e-05	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH3—esophageal cancer	3.68e-05	0.000224	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GHRL—esophageal cancer	3.68e-05	0.000224	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALDOB—esophageal cancer	3.68e-05	0.000224	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GNG7—esophageal cancer	3.66e-05	0.000223	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.66e-05	0.000223	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTT1—esophageal cancer	3.65e-05	0.000223	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FBXW7—esophageal cancer	3.62e-05	0.00022	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	3.61e-05	0.00022	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.6e-05	0.000219	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA2—esophageal cancer	3.59e-05	0.000219	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GNG7—esophageal cancer	3.57e-05	0.000218	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.57e-05	0.000217	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.54e-05	0.000216	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.54e-05	0.000216	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.51e-05	0.000214	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALDH2—esophageal cancer	3.43e-05	0.000209	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ENO1—esophageal cancer	3.42e-05	0.000209	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS1—esophageal cancer	3.42e-05	0.000209	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PSME1—esophageal cancer	3.37e-05	0.000206	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PSME2—esophageal cancer	3.37e-05	0.000206	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.37e-05	0.000205	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALDH2—esophageal cancer	3.35e-05	0.000204	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.34e-05	0.000203	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.34e-05	0.000203	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GNG7—esophageal cancer	3.34e-05	0.000203	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH2—esophageal cancer	3.3e-05	0.000201	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTT1—esophageal cancer	3.26e-05	0.000199	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	3.22e-05	0.000196	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.21e-05	0.000196	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTT1—esophageal cancer	3.18e-05	0.000194	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.15e-05	0.000192	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.15e-05	0.000192	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.13e-05	0.00019	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS1—esophageal cancer	3.06e-05	0.000186	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ENO1—esophageal cancer	3.06e-05	0.000186	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PSME2—esophageal cancer	3.01e-05	0.000183	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PSME1—esophageal cancer	3.01e-05	0.000183	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—esophageal cancer	3e-05	0.000183	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ENO1—esophageal cancer	2.98e-05	0.000182	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.98e-05	0.000182	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.98e-05	0.000182	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.97e-05	0.000181	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.97e-05	0.000181	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.95e-05	0.000179	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.94e-05	0.000179	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PSME1—esophageal cancer	2.94e-05	0.000179	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PSME2—esophageal cancer	2.94e-05	0.000179	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.93e-05	0.000178	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.93e-05	0.000178	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFBR2—esophageal cancer	2.93e-05	0.000178	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.91e-05	0.000177	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ENO1—esophageal cancer	2.81e-05	0.000171	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.81e-05	0.000171	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.8e-05	0.00017	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ENO1—esophageal cancer	2.79e-05	0.00017	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.79e-05	0.00017	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SMAD4—esophageal cancer	2.77e-05	0.000169	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSME2—esophageal cancer	2.77e-05	0.000169	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSME1—esophageal cancer	2.77e-05	0.000169	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSME1—esophageal cancer	2.75e-05	0.000167	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSME2—esophageal cancer	2.75e-05	0.000167	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.74e-05	0.000167	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.72e-05	0.000166	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.65e-05	0.000161	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.63e-05	0.00016	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.6e-05	0.000158	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.54e-05	0.000154	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.53e-05	0.000154	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.53e-05	0.000154	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.5e-05	0.000152	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.45e-05	0.000149	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.44e-05	0.000149	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.43e-05	0.000148	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.4e-05	0.000146	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.4e-05	0.000146	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.39e-05	0.000146	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.38e-05	0.000145	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.37e-05	0.000144	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.33e-05	0.000142	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.31e-05	0.000141	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—esophageal cancer	2.27e-05	0.000138	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.25e-05	0.000137	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.23e-05	0.000136	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.23e-05	0.000136	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.2e-05	0.000134	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.19e-05	0.000133	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—esophageal cancer	2.18e-05	0.000133	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—esophageal cancer	2.17e-05	0.000132	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.14e-05	0.00013	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.06e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.05e-05	0.000125	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH1—esophageal cancer	2.04e-05	0.000124	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.03e-05	0.000124	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.99e-05	0.000121	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.97e-05	0.00012	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.96e-05	0.000119	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.95e-05	0.000119	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.94e-05	0.000118	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREBBP—esophageal cancer	1.85e-05	0.000113	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.84e-05	0.000112	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.84e-05	0.000112	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—esophageal cancer	1.82e-05	0.000111	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.81e-05	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.81e-05	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.81e-05	0.00011	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.74e-05	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—esophageal cancer	1.66e-05	0.000101	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.62e-05	9.85e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.6e-05	9.76e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	1.58e-05	9.62e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.56e-05	9.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—esophageal cancer	1.55e-05	9.44e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.48e-05	8.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.47e-05	8.95e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—esophageal cancer	1.43e-05	8.74e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.43e-05	8.71e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.4e-05	8.5e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—esophageal cancer	1.37e-05	8.34e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.34e-05	8.17e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	1.33e-05	8.07e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.32e-05	8.01e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.31e-05	7.99e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.3e-05	7.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.29e-05	7.84e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—esophageal cancer	1.28e-05	7.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EP300—esophageal cancer	1.26e-05	7.68e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—esophageal cancer	1.25e-05	7.61e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.18e-05	7.17e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.17e-05	7.13e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.17e-05	7.11e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.14e-05	6.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—esophageal cancer	1.1e-05	6.69e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—EP300—esophageal cancer	1.09e-05	6.65e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.08e-05	6.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—esophageal cancer	1.07e-05	6.55e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.07e-05	6.5e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—EP300—esophageal cancer	9.74e-06	5.93e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—EP300—esophageal cancer	9.51e-06	5.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	9.33e-06	5.68e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—esophageal cancer	9.02e-06	5.5e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—EP300—esophageal cancer	8.96e-06	5.46e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—EP300—esophageal cancer	8.88e-06	5.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.6e-06	5.24e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	8.07e-06	4.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—esophageal cancer	7.7e-06	4.69e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	7.21e-06	4.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.04e-06	4.29e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.03e-06	4.28e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6.63e-06	4.04e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	6.57e-06	4e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—EP300—esophageal cancer	5.86e-06	3.57e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.33e-06	2.64e-05	CbGpPWpGaD
